‘It’s a murky business’: the row over levothyroxine use in ‘subclinical’ disease
As the rising use of levothyroxine sparks concern, experts are disagreeing about how to approach the significant number of patients with conflicting levels of thyroid hormones, who often have no symptoms at all.…